Journal article
Well-being and stress vulnerability in ovarian cancer survivors during the COVID-19 pandemic
Journal of psychosocial oncology, Vol.42(3), pp.299-314
2024
DOI: 10.1080/07347332.2023.2244474
PMCID: PMC10873467
PMID: 37587850
Abstract
Objective:
This study was designed to examine (1) whether ovarian cancer (OC) survivors would have greater well-being vs. elevated distress compared to community members during a universal health stressor (COVID-19) and (2) how resources and risk factors at diagnosis predicted vulnerability to a subsequent health-related stressor.
Methods:
One hundred seventeen OC survivors were recruited from two academic medical centers and compared to a community-based sample on COVID-related distress and disruption. Latent class analysis identified differentially impacted groups of survivors.
Results:
Survivors reported lower distress than community members. Predictors of higher distress included shorter-term survivorship, greater disruption, and poorer emotional well-being (EWB) at diagnosis. Survivors were divided into high- and low-COVID-19-impact subgroups; high-impact individuals endorsed higher perceived stress and lower EWB at diagnosis.
Conclusion:
Survivors reported lower COVID-related distress than community participants. While depression at diagnosis did not predict later distress, EWB was a strong predictor of response to a novel health-related stressor.
Details
- Title: Subtitle
- Well-being and stress vulnerability in ovarian cancer survivors during the COVID-19 pandemic
- Creators
- Rachel Telles - University of IowaSharaf Zia - University of IowaBreanna Greteman - University of IowaPremal Thaker - Washington University in St. LouisFrank Penedo - Sylvester Comprehensive Cancer CenterMary Charlton - University of IowaMichael Goodheart - University of IowaJessica Armer - University of IowaAlyssa Noble - University of IowaAnil Sood - The University of Texas MD Anderson Cancer CenterSusan Lutgendorf - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Journal of psychosocial oncology, Vol.42(3), pp.299-314
- DOI
- 10.1080/07347332.2023.2244474
- PMID
- 37587850
- PMCID
- PMC10873467
- NLM abbreviation
- J Psychosoc Oncol
- ISSN
- 0734-7332
- eISSN
- 1540-7586
- Grant note
- name: NIH, award: CA193249, CA246540, CA109298, CA209904; DOI: 10.13039/100000048, name: American Cancer Society (AKS; name: the University of Iowa Holden Comprehensive Cancer Center, award: 3P30CA086862; name: the University of Iowa Holden Comprehensive Cancer Center COVID-19 Supplement, award: 3P30CA086862-19S5; DOI: 10.13039/100006108, name: National Center for Advancing Translational Sciences of the NIH, award: UL1TR002537
- Language
- English
- Electronic publication date
- 08/17/2023
- Date published
- 2024
- Academic Unit
- Epidemiology; Psychological and Brain Sciences; Iowa Neuroscience Institute; Obstetrics and Gynecology; Writers’ Workshop; Urology
- Record Identifier
- 9984459413802771
Metrics
15 Record Views